Select Medical Holdings Corporation (SEM)

Select Medical Holdings Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	5,521	5,453	5,187	4,826	4,609	6,205
Revenue Growth	5.79%	5.12%	7.48%	4.70%	-25.71%	12.16%
Gross Profit Gross Profit Growth	921.02	924.8	915.54	836.47	655.59	1,264
Operating Income Operating Income Growth	321.84	336.17	268.32	267.24	116.3	570.07
Net Income Net Income Growth	130.13	142.87	211.72	241.36	159.52	388.79
Earnings Per Share EPS Growth	1.07	1.16	1.70	1.96	1.28	2.98
EPS Growth	-21.82%	-31.44%	-13.35%	53.18%	-57.12%	54.90%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Critical Illness Recovery Hospital Critical Illness Recovery Hospital Growth	2,480	2,478	2,444	2,300	2,234	2,247
Rehabilitation Hospital Rehabilitation Hospital Growth	1,334	1,289	1,111	979.59	916.76	849.34
Outpatient Rehabilitation Outpatient Rehabilitation Growth	1,299	1,285	1,250	1,189	1,125	1,084
Other Segment Other Segment Growth	409.24	401.19	382.02	357.71	333	292
Revenue (Total) Revenue (Total) Growth	5,521	5,453	5,187	4,826	4,609	6,205

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	25.68	26.52	59.69	111.59	172.76	74.31
Total Debt Total Debt Growth	2,992	2,869	2,704	4,525	5,157	4,763
Net Cash (Debt) Net Cash Growth	-2,967	-2,842	-2,645	-4,413	-4,984	-4,688
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-24.46	-23.17	-21.22	-35.85	-39.99	-35.99

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	387.78	346.47	517.86	582.06	284.83	401.23
Capital Expenditures CapEx Growth	-235.78	-229.23	-222.18	-229.2	-190.37	-180.54
Free Cash Flow Free Cash Flow Growth	152	117.24	295.69	352.86	94.45	220.69
Free Cash Flow Growth	-57.67%	-60.35%	-16.20%	273.58%	-57.20%	-74.97%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	16.68%	16.96%	17.65%	17.33%	14.22%	20.36%
Operating Margin	5.83%	6.17%	5.17%	5.54%	2.52%	9.19%
Pretax Margin	4.68%	5.00%	3.37%	2.90%	0.77%	10.15%
Profit Margin	2.36%	2.62%	4.08%	5.00%	3.46%	6.27%
FCF Margin	2.75%	2.15%	5.70%	7.31%	2.05%	3.56%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.250	0.250	0.438	0.500	0.500	0.500
Dividend Per Share Growth	-33.33%	-42.86%	-12.50%	0%	0%	-
Dividend Yield	1.51%	1.70%	2.38%	4.12%	3.97%	3.42%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	15.38	12.87	11.49	12.48	19.77	10.14
Forward PE	12.69	12.27	13.19	10.93	12.92	10.87
P/FCF Ratio	13.47	15.68	8.22	8.54	33.38	17.87
PS Ratio	0.37	0.34	0.47	0.62	0.68	0.64

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error